פריוריקס טטרה

Šalis: Izraelis

kalba: hebrajų

Šaltinis: Ministry of Health

Veiklioji medžiaga:

LIVE ATTENUATED MEASLES VIRUS; LIVE ATTENUATED MUMPS VIRUS; LIVE ATTENUATED RUBELLA VIRUS; LIVE ATTENUATED VARICELLA VIRUS

Prieinama:

GLAXO SMITH KLINE (ISRAEL) LTD

ATC kodas:

J07BD54

Vaisto forma:

אבקה וממס להכנת תמיסה להזרקה

Sudėtis:

LIVE ATTENUATED MEASLES VIRUS 10^ 3.0 CCID50; LIVE ATTENUATED MUMPS VIRUS 10^ 4.4 CCID50; LIVE ATTENUATED RUBELLA VIRUS 10^ 3.0 CCID50; LIVE ATTENUATED VARICELLA VIRUS 10^ 3.3 PFU

Vartojimo būdas:

תת-עורי

Recepto tipas:

מרשם נדרש

Pagaminta:

GLAXO SMITH KLINE BIOLOGICALS S.A

Farmakoterapinė grupė:

MEASLES, COMBINATIONS WITH MUMPS, RUBELLA AND VARICELLA, LIVE ATTENUATED

Gydymo sritis:

MEASLES, COMBINATIONS WITH MUMPS, RUBELLA AND VARICELLA, LIVE ATTENUATED

Terapinės indikacijos:

Priorix-Tetra is indicated for active immunisation against measles, mumps, rubella and varicella in children from the age of 12 months up and including 12 years of age.

Leidimo data:

2023-07-31